DMCC Speciality Chemicals Ltd Q4 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/mrpis37h12lu71w2i770d487.pdf

Key Takeaways


Demand & Pricing Environment

Goculdas: "Now again because of easy logistics, that whole supply chain risk, all the purchasing managers have forgotten. So, let there be some kind of a consolidation phase. Where there's an uptick in the market, I think there will be much more traction for new products."

Operational Performance

Goculdas: "Mathematically if your margin remains the same in absolute terms, but your prices come down for both raw materials and finished products, then as a percentage it increases, you may see a better margin at lower prices and then a lower margin at higher prices, but not necessarily in absolute terms."

Capex, Debt & Capital Allocation

Goculdas: "With so much uncertainty right now, we are not looking at any major large investments. If you had a look at the cash flow, we started paying down some of the loans. And I think with the high interest rates and everything, that is more prudent thing to do."

Product Mix & Downstream Potential


R&D, Technology & Strategic Positioning

Goculdas: "In fact, according to me personally, I believe that for the hazardous chemicals, and particularly for upstream, it is more important to go to flow chemistry than the pharma industry, because we are handling larger volumes, more dangerous chemicals, we would benefit much more from movement towards flow chemistry."

Guidance & Commitments

CommitmentSpecificsTimeline
Bulk-speciality mix shiftMove from 40:60 to 30:70 splitGoing forward, depending on prices
Demand recoveryOptimism returns only after interest rate cycle eases and Europe crisis resolvesNot until "this whole year"
Downstream utilization upsideAt least 30–40% additional volume possible at DahejNo date (capacity available)
CapexNot a significant number, nothing compared to last two yearsFY24–FY25
R&D spendContinue at 1–2% of top line"For a while"
Sustainability projectOne more project to be completed, reducing carbon footprint substantiallyThis year

Key Metrics

MetricQ4 FY23
Revenue₹94 cr, lower than ₹104 cr in Q4 FY22 due to lower pricing, though volumes were substantially better
EBITDA₹17 cr
EBITDA margin~18%
Profit before tax~₹9 cr
PBT margin~10%
Bulk vs speciality chemicals split40:60
FY23 exports growth61% over FY22
Sulfuric acid plant capacity utilization90% and upward
Downstream products upside after Dahej expansionsat least 30% to 40% extra (management estimate)
Downstream products quarterly run rate potential at optimal capacity₹130–140 cr, up from around ₹100 cr (per an analyst's math)
R&D spend1% to 2% of top line
Sulfur required per ton of sulfuric acid0.33 or 0.34 tons